Refoxy Pharma Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $9.6M

  • Investors
  • 8

Refoxy Pharma General Information

Description

Developer of therapeutic medicines designed to treat age-related diseases and improve healthy longevity. The company researches proteins that regulate multiple genes involved in processes like stress resistance, and metabolism and develops novel modulators of a central stress response pathway to modulate aging through genetics, enabling patients to extend the years of healthy living.

Contact Information

Website
www.refoxy.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Care of Startplatz
  • Im Mediapark 5
  • 50670 Cologne
  • Germany
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Care of Startplatz
  • Im Mediapark 5
  • 50670 Cologne
  • Germany

Refoxy Pharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Refoxy Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 04-Dec-2024 $9.6M Completed Pre-Clinical Trials
4. Seed Round 30-Nov-2022 Completed Pre-Clinical Trials
3. Seed Round 01-Aug-2021 Completed Pre-Clinical Trials
2. Accelerator/Incubator Completed Pre-Clinical Trials
1. Accelerator/Incubator Completed Pre-Clinical Trials
To view Refoxy Pharma’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Refoxy Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Refoxy Pharma Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Boehringer Ingelheim Venture Fund Corporate Venture Capital Minority
High-Tech Gründerfonds Venture Capital Minority
NRW BANK Investment Bank Minority
Infinitas Capital Family Office Minority
Korify Capital Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Refoxy Pharma FAQs

  • When was Refoxy Pharma founded?

    Refoxy Pharma was founded in 2020.

  • Where is Refoxy Pharma headquartered?

    Refoxy Pharma is headquartered in Cologne, Germany.

  • What is the size of Refoxy Pharma?

    Refoxy Pharma has 4 total employees.

  • What industry is Refoxy Pharma in?

    Refoxy Pharma’s primary industry is Drug Discovery.

  • Is Refoxy Pharma a private or public company?

    Refoxy Pharma is a Private company.

  • What is Refoxy Pharma’s current revenue?

    The current revenue for Refoxy Pharma is .

  • How much funding has Refoxy Pharma raised over time?

    Refoxy Pharma has raised $9.9M.

  • Who are Refoxy Pharma’s investors?

    Boehringer Ingelheim Venture Fund, High-Tech Gründerfonds, NRW BANK, Infinitas Capital, and Korify Capital are 5 of 8 investors who have invested in Refoxy Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process